Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Zero Based Budgeting strategies help you prioritize spending and eliminate waste. Learn effective approaches to improve your financial plan.
19,194 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Berkshire Hathaway cut a large portion of its Amazon position and deployed capital into The New York Times, a calcula...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
The weekend U.S.–Iran strike left traditional markets offline, putting on-chain platforms at the center of price disc...
A notable hedge fund takes a sizable new position in SentinelOne, signaling growing confidence in AI-driven cybersecu...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...
Uber stock has slipped about 12% in three months, trading near $74 after a strong run. This article breaks down what’...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
The term stagflation can spark fear, but panicking won’t help. This guide breaks down what stagflation starting rear ...
Markets are unsettled, but long-term investors can find value. This guide highlights three AI leaders that are curren...
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...